Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and Behavioral Support for Smoking Cessation in Hospitalized Patients
NCT02922387Phase 4Completed
- Sponsor
- General Hospital of Kavala
- Start
- May 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of varenicline in Tobacco Use Disorder (TUD) (2 arms), sponsored by General Hospital of Kavala. Primary endpoint: Smoking Cessation Rate at week 52. Started May 2012; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02922387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922387.